Class II recall: ACCORD HEALTHCARE, INC.: Levothyroxine Sodium Tablets, USP, 112 mcg (0.112 mg), 1000-count bottles, Rx On
Accord Healthcare, Inc. issued a Class II recall of Levothyroxine Sodium Tablets, USP, 112 mcg (0.112 mg), in 1000-count bottles, NDC 16729-452-17. The product was manufactured by Intas Pharmaceuticals Limited in India and distributed for Accord Healthcare in Raleigh, NC. The recall reason cited is that the drug is subpotent.
Most relevant for: Patients prescribed the 112 mcg levothyroxine sodium tablets from this specific lot for management of hypothyroidism.
Read the original at FDA Drug Enforcement ReportsSummary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.
Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.
Specialties
More cardiology updates
- OCEANIC-STROKE: Asundexian Not Linked to More Major BleedingOct 13, 2026
- ACC Statement Backs Whole-Food Diets Over Isolated NutrientsSep 30, 2026
- Oral GLP-1 drug orforglipron meets cardiovascular non-inferiority vs insulin glargineSep 30, 2026
- Stroke center status skews TAVR stroke rates in national registrySep 29, 2026
- Retatrutide produces substantial weight loss in phase 3 diabetes trialSep 29, 2026